The following is a summary of "Impact Of Hypercortisolism Beyond Metabolic Syndrome On Left Ventricular Performance: A Myocardial Work Analysis,” published in the March 2025 issue of Cardiovascular ...

Anant Ambani is taking a 170km long spiritual walk from Jamnagar to Dwarka, walking 20 km every night for seven hours in the run-up to his 30th birthday. Anant has faced significant health challenges, ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic ...

The phase 3 trial showed relacorilant with chemotherapy improved progression-free and overall survival in platinum-resistant ...

CORT's Cushing's syndrome drug, Korlym, is driving revenues. The FDA's acceptance of the NDA for relacorilant also bodes well.

H.C. Wainwright's research, including a survey of endocrinologists, indicates a gap in the identification of hypercortisolism in type 2 diabetes patients. The survey revealed that most ...